抗骨诱导因子(OGN)多克隆抗体

Anti-Osteoglycin (OGN) Polyclonal Antibody

OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor

  • 抗骨诱导因子(OGN)多克隆抗体 产品包装(模拟)
  • 抗骨诱导因子(OGN)多克隆抗体 产品包装(模拟)
  • 抗骨诱导因子(OGN)多克隆抗体 Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-rat OGN Polyclonal Antibody (Catalog FAC688Ra01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

用法

Flow cytometry: 20µg/ml;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。

赠品

相关产品

编号 适用物种:Rattus norvegicus (Rat,大鼠) 应用(仅供研究使用,不用于临床诊断!)
URPC688Ra01 骨诱导因子(OGN)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAC688Ra01 骨诱导因子(OGN)多克隆抗体 WB
UFAC688Ra01 抗骨诱导因子(OGN)多克隆抗体 FCM
ULAC688Ra71 骨诱导因子(OGN)多克隆抗体(生物素标记) WB

参考文献

杂志 参考文献
Bone. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. [pubmed:27836731]
Tohoku journal of experimental medicine Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. [pubmed:28824047]
Molecular Metabolism Osteoglycin, a novel coordinator of bone and glucose homeostasis [Pubmed:29799418]
Journal of Experimental & Clinical Cancer Research Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway [Pubmed:29499765]
Journal of Human Hypertension Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients [Pubmed:29867136]
Cell Reports Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue [Pubmed: 30332637]
J Clin Endocrinol Metab Osteoglycin across the adult lifespan [34850904]
留言咨询